4-叔丁基苯甲酸丙酯 | 6282-27-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-叔丁基苯甲酸丙酯
• 英文名称: propyl 4-tert-butylbenzoate
• 英文别名: 4-tert.-Butyl-benzoesaeure-propylester
• CAS: 6282-27-5
• 化学式: C₁₄H₂₀O₂
• mdl: MFCD12178056
• 分子量: 220.312
• InChiKey: IFFIRJMHMXRNHD-UHFFFAOYSA-N

物化性质

• 沸点：
  295.5±19.0 °C(Predicted)
• 密度：
  0.970±0.06 g/cm3(Predicted)
• 保留指数：
  1641

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-叔丁基苯甲酸丙酯 在 一水合肼 作用下， 生成 对叔丁基苯甲酰肼
  参考文献：
  名称：

  Physicochemical properties of 4-tert-butylbenzoic acid N′,N′-dialkylhydrazides

  摘要：

  DOI：

  10.1134/s1070363214060085
• 作为产物：
  描述：

  丙醇 、 4-叔丁基甲苯 在 蒽醌-2,3-二甲酸 、 氧气 、 三氟乙酸 作用下， 反应 24.0h， 以68%的产率得到4-叔丁基苯甲酸丙酯
  参考文献：
  名称：

  Direct aerobic photo-oxidative syntheses of aromatic methyl esters from methyl aromatics using anthraquinone-2,3-dicarboxylic acid as organophotocatalyst

  摘要：

  本文报道了一种通过使用蒽醌-2,3-二羧酸作为有机光催化剂进行有氧光氧化，从甲基芳烃直接合成芳香甲酯的简便方法。

  DOI：

  10.1039/c2pp05387j

文献信息

• Solvent-Free Esterification of Carboxylic Acids and Alcohols in the Presence of Silphos [PCl_3-n(SiO₂)_n] as a Heterogeneous Phosphine Reagent
  作者：Ambati Narasimha Rao、Kumaran Ganesan、Chandra Kant Shinde

  DOI：10.1080/00397911.2011.555903

  日期：2012.8.1

  Abstract An efficient solvent-free method for the preparation of esters from various aromatic and aliphatic acids with primary, secondary, and tertiary alcohols using a heterogeneous phosphine reagent, silphos [PCl3-n(SiO2)n], in good yields is reported. GRAPHICAL ABSTRACT

  摘要 报道了一种使用多相膦试剂 silphos [PCl3-n(SiO2)n] 从各种芳香族和脂肪酸与伯醇、仲醇和叔醇制备酯的有效无溶剂方法，收率良好。图形概要
• SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF
  申请人：Arizona Board of Regents on Behalf of the University of Arizona

  公开号：US20200039989A1

  公开（公告）日：2020-02-06

  This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a 6,5-heterocyclic structure (e.g., compounds having a imidazopyridine, imidazopyrimidine, imidazopyrazine, imidazopyridazine, imidazotriazine, benzoimidazole, benzotriazole, benzoisoxazole, purine, indazole, triazolotriazine, triazolopyridazine, triazolopyrimidine, triazolopyrazine, triazolotetrazine, triazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolopyridazine, pyrazolotriazine, pyrazolopyridine, isoxazolopyrazine, isoxazolopyrimidine, isoxazolopyrdiazine, isoxazolotriazine, or isoxalopyridine structure) which function as inhibitors of DYRK1A, DYRK1B, and Clk-1, and their use as therapeutics for the treatment of Alzheimer's disease, Down syndrome, diabetes, glioblastoma, autoimmune diseases, cancer (e.g., glioblastoma, prostate cancer), inflammatory disorders (e.g., airway inflammation), and other diseases.

  这项发明属于药物化学领域。具体来说，该发明涉及一类新型小分子，具有6,5-杂环结构（例如，具有咪唑吡啶、咪唑吡嘧啶、咪唑吡嗪、咪唑吡啶嗪、咪唑三嗪、苯并咪唑、苯并三唑、苯并异嗪、嘌呤、吲唑、三唑三嗪、三唑吡啶嗪、三唑吡嘧啶、三唑吡嗪、三唑四嗪、三唑吡啶、吡唑吡嗪、吡唑吡嘧啶、吡唑吡啶嗪、吡唑三嗪、吡唑吡啶、异嗪吡嗪、异嗪吡嘧啶、异嗪吡啶嗪、异嗪三嗪、或异嗪吡啶结构），其作为DYRK1A、DYRK1B和Clk-1的抑制剂，以及它们作为治疗阿尔茨海默病、唐氏综合征、糖尿病、胶质母细胞瘤、自身免疫疾病、癌症（例如，胶质母细胞瘤、前列腺癌）、炎症性疾病（例如，气道炎症）和其他疾病的治疗药物的用途。
• Multicomponent Reaction: Palladium-Catalyzed Carbonylation of Aryl Halides and Alkyl Halides to Aromatic Esters
  作者：Fengxiang Zhu、Pengpeng Yin、Pengbo Zhang

  DOI：10.1021/acs.joc.2c01794

  日期：——

  A convenient four-component reaction has been developed that allows for the direct transformation of aryl iodides with alkyl halides into the corresponding aromatic esters and diesters via palladium-catalyzed carbonylation with water as solvent. Various esters and diesters were isolated in moderate to good yields with broad functional group tolerance.

  已经开发出一种方便的四组分反应，允许通过钯催化的以水为溶剂的羰基化将芳基碘与烷基卤化物直接转化为相应的芳族酯和二酯。各种酯和二酯以中等到良好的收率分离，具有广泛的官能团耐受性。
• Small molecule inhibitors of DYRK1A and uses thereof
  申请人：ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA

  公开号：US10730842B2

  公开（公告）日：2020-08-04

  This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a benzimidazole or imidazopyridine structure which function as inhibitors of DYRK1A protein, and their use as therapeutics for the treatment of Alzheimer's disease, Down syndrome, glioblastoma, autoimmune diseases, inflammatory disorders (e.g., airway inflammation), and other diseases.

  本发明属于药物化学领域。特别是，本发明涉及一类具有苯并咪唑或咪唑吡啶结构的新型小分子，它们可作为 DYRK1A 蛋白的抑制剂，并可用作治疗阿尔茨海默病、唐氏综合征、胶质母细胞瘤、自身免疫性疾病、炎症性疾病（如气道炎症）和其他疾病的疗法。
• Aerobic oxidative esterification of benzyl alcohols with catalytic tetrabromomethane under visible light irradiation
  作者：Tomoya Nobuta、Akitoshi Fujiya、Shin-ichi Hirashima、Norihiro Tada、Tsuyoshi Miura、Akichika Itoh

  DOI：10.1016/j.tetlet.2012.07.091

  日期：2012.9

  We report a useful method for the facile synthesis of aromatic esters from benzyl alcohols with molecular oxygen and catalytic tetrabromomethane in alcohol under visible light irradiation with a fluorescent lamp. This is the first metal-free reaction using molecular oxygen as the terminal oxidant. (c) 2012 Elsevier Ltd. All rights reserved.